Is Faricimab-svoa effective against diabetic macular edema?

Question

Hello doctor,

I am concerned about my father-in-law, who was recently diagnosed with diabetic macular edema. He has been taking Metformin 500 mg for the past 12 years, but his sugar levels continue to fluctuate. Now, he seems worried that he might lose his vision due to macular edema. Is this true? The doctor has suggested Faricimab-svoa. Is this a safe drug? Will it cause any interactions with Metformin? What measures should he follow while taking this medicine, and will it cure his problem?

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I have read your query, and I can understand your concern.

Faricimab-svoa is a prescription medicine administered by injection into the eye. It is the first and only FDA (Food and Drug Administration)-approved treatment designed to block two causes of diabetic macular edema, which are VEGF (Vascular Endothelial Growth Factor) and Ang-2 (Angiopoietin-2). Other drugs typically only block VEGF, making it particularly suitable for use in individuals with diabetic macular edema. Do not receive Faricimab-svoa if you:

Have an infection in or around your eye.
Have active swelling around your eye that may include pain and redness.
Are allergic to Faricimab-svoa or any of the ingredients in Faricimab-svoa.

There are monitoring requirements that you must be aware of:

Injections like the one for Faricimab-svoa can cause an eye infection (endophthalmitis), separation of layers of the retina (retinal detachment), or inflammation in the eye that can lead to vision loss. Contact your healthcare provider immediately if your eye becomes red, or sensitive to light, or if you experience a change or loss of vision.
Faricimab-svoa may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs within 60 minutes after receiving the eye injection.
Although not common, Faricimab-svoa patients have experienced serious, sometimes fatal problems related to blood clots, such as heart attacks or strokes (thromboembolic events); therefore, monitoring for these is essential.

I hope your queries are resolved, and any further queries are welcome.

Thank you.